These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24652317)

  • 21. Fibrous meningioma in a patient with von Hippel-Lindau disease: a genetic analysis.
    Governale LS; Vortmeyer AO; Zhuang Z; Oldfield EH
    J Neurosurg; 2001 Dec; 95(6):1045-9. PubMed ID: 11765821
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Focal Adhesion Kinase as a Therapeutic Target for Meningiomas With Somatic Neurofibromatosis Type 2 Mutations.
    Mason WP
    J Clin Oncol; 2023 Jan; 41(3):675-677. PubMed ID: 36288506
    [No Abstract]   [Full Text] [Related]  

  • 23. Hereditary tumors of the nervous system.
    Ponz de Leon M
    Recent Results Cancer Res; 1994; 136():84-93. PubMed ID: 7863109
    [No Abstract]   [Full Text] [Related]  

  • 24. Report of the third international workshop on human chromosome 22 mapping.
    Emanuel BS; Buetow K; Nussbaum R; Scambler P; Lipinski M; Overton GC
    Cytogenet Cell Genet; 1993; 63(4):206-11. PubMed ID: 8099004
    [No Abstract]   [Full Text] [Related]  

  • 25. Current standing and frontiers of gene therapy for meningiomas.
    De La Garza-Ramos R; Flores-Rodríguez JV; Martínez-Gutiérrez JC; Ruiz-Valls A; Caro-Osorio E
    Neurosurg Focus; 2013 Dec; 35(6):E4. PubMed ID: 24289129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of genes differentially expressed in meningiomas.
    Murphy M; Pykett MJ; Harnish P; Zang KD; George DL
    Cell Growth Differ; 1993 Sep; 4(9):715-22. PubMed ID: 7694637
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal tumors in neurofibromatosis-2: management considerations - a review.
    Holland K; Kaye AH
    J Clin Neurosci; 2009 Feb; 16(2):169-77. PubMed ID: 19101145
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.
    Zhang X; Jia H; Lu Y; Dong C; Hou J; Wang Z; Wang F; Zhong H; Wang L; Wang K
    Discov Med; 2014 Dec; 18(101):301-311. PubMed ID: 25549701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of sex-ratio distortion in neurofibromatosis 2.
    Baser ME; Evans DG
    Am J Med Genet; 2000 Nov; 95(3):292. PubMed ID: 11102942
    [No Abstract]   [Full Text] [Related]  

  • 30. First insight into the somatic mutation burden of neurofibromatosis type 2-associated grade I and grade II meningiomas: a case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation.
    Dewan R; Pemov A; Dutra AS; Pak ED; Edwards NA; Ray-Chaudhury A; Hansen NF; Chandrasekharappa SC; Mullikin JC; Asthagiri AR; ; Heiss JD; Stewart DR; Germanwala AV
    BMC Cancer; 2017 Feb; 17(1):127. PubMed ID: 28193203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infratentorial meningioma in an 8-year-old child as first sign of neurofibromatosis type 2.
    Stettner GM; Rostasy KM; Ludwig HC; Merkler D; Fahsold R; Gärtner J
    Neuropediatrics; 2007 Feb; 38(1):29-31. PubMed ID: 17607601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A patient with mosaic neurofibromatosis type 2 presenting with early onset meningioma.
    Chu YW; Cheuk DK; Chung BH; Bowers NL; Ha SY; Chiang AK; Chan GC
    BMJ Case Rep; 2014 Nov; 2014():. PubMed ID: 25406210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic and epigenetic alteration of the NF2 gene in sporadic meningiomas.
    Lomas J; Bello MJ; Arjona D; Alonso ME; Martinez-Glez V; Lopez-Marin I; Amiñoso C; de Campos JM; Isla A; Vaquero J; Rey JA
    Genes Chromosomes Cancer; 2005 Mar; 42(3):314-9. PubMed ID: 15609345
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Future treatment modalities for meningiomas: targeting of neurofibromatosis type 2 and Ras-regulated pathways.
    Evans JJ; Lee JH; Park YS; Jeun SS; Harwalkar JA; Safayhi H; Golubic M
    Neurosurg Clin N Am; 2000 Oct; 11(4):717-33. PubMed ID: 11082181
    [No Abstract]   [Full Text] [Related]  

  • 35. Molecular genetic investigation of the neurofibromatosis type 2 tumor suppressor gene in sporadic meningioma.
    Harada T; Irving RM; Xuereb JH; Barton DE; Hardy DG; Moffat DA; Maher ER
    J Neurosurg; 1996 May; 84(5):847-51. PubMed ID: 8622160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neurofibromatosis type 2: a new mechanism of tumor suppression.
    Lutchman M; Rouleau GA
    Trends Neurosci; 1996 Sep; 19(9):373-7. PubMed ID: 8873351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial meningioma: analysis of expression of neurofibromatosis 2 protein Merlin. Report of two cases.
    Maxwell M; Shih SD; Galanopoulos T; Hedley-Whyte ET; Cosgrove GR
    J Neurosurg; 1998 Mar; 88(3):562-9. PubMed ID: 9488313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular biological analysis of neurofibromatosis type 2 gene].
    Ichimura K; Yuasa Y
    Nihon Rinsho; 1993 Sep; 51(9):2462-6. PubMed ID: 8411729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Animal models of meningiomas.
    Mawrin C
    Chin Clin Oncol; 2017 Jul; 6(Suppl 1):S6. PubMed ID: 28595424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genomic analysis of non-neurofibromatosis type 2 meningiomas.
    Parry PV; Engh JA
    Neurosurgery; 2013 Jun; 72(6):N18-9. PubMed ID: 23685513
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.